Drug profile

The FDA adverse-event record for Unknown Medicated Shampoo

Name: Unknown Medicated Shampoo - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

11 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unknown Medicated Shampoo. See the species affected, top reactions, and outcomes below.

11
adverse-event reports: 0.0%
death-coded share: Dog
most-reported species: 3
Lack of efficacy (ectoparasite) - flea - top reaction

Compiled by PlainBreed Editorial, Pet Health Editorial Team

Verify with FDA CVM →

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Unknown Medicated Shampoo

Administration Routes

UnknownTopical

Species Affected

Dog 11

Most Affected Breeds

Dachshund (unspecified) 2

Shepherd Dog - Australian 2

Collie - Border 2

Schnauzer - Miniature 1

Bulldog - French 1

Shih Tzu 1

Shepherd Dog - German 1

Crossbred Canine/dog 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 3

Ear infection NOS 3

Lack of efficacy - NOS 3

Lethargy (see also Central nervous system depression in 'Neurological') 2

Hair shedding 2

Scratching 2

Seizure NOS 2

Hair loss NOS 2

Elevated liver enzymes NOS 2

Hives (see also 'Skin') 1

Emesis 1

Shaking 1

Outcome Breakdown

Ongoing

7 (63.6%)

Outcome Unknown

3 (27.3%)

Recovered/Normal

1 (9.1%)

Unknown Medicated Shampoo Adverse Event Insights

11 reports name Unknown Medicated Shampoo; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Unknown Medicated Shampoo. Administration routes: Unknown, Topical.

By species: Dog (11 reports). By breed: Dachshund (unspecified) (2), Shepherd Dog - Australian (2), Collie - Border (2).

Leading clinical signs: Lack of efficacy (ectoparasite) - flea (3), Ear infection NOS (3), Lack of efficacy - NOS (3), Lethargy (see also Central nervous system depression in 'Neurological') (2). Outcome, 11 coded reports: Ongoing leads at 63.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.